Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

about

Serum neurofilament light chain is increased in hereditary spastic paraplegias.

P2860

Q55669686-86CA20C6-2647-4231-9011-4F17A9005BFB

P2860

Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q47416181

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hereditary spastic paraplegia ...... a randomized controlled trial.

@en

Hereditary spastic paraplegia ...... a randomized controlled trial.

@nl

type

Item

label

Hereditary spastic paraplegia ...... a randomized controlled trial.

@en

Hereditary spastic paraplegia ...... a randomized controlled trial.

@nl

prefLabel

Hereditary spastic paraplegia ...... a randomized controlled trial.

@en

Hereditary spastic paraplegia ...... a randomized controlled trial.

@nl

P1476

Hereditary spastic paraplegia ...... a randomized controlled trial.

@en

P2093

Alessandro Filla

http://www.w3.org/2001/XMLSchema#string

Alessia Arnoldi

http://www.w3.org/2001/XMLSchema#string

Andrea Martinuzzi

http://www.w3.org/2001/XMLSchema#string

Antonella Antenora

http://www.w3.org/2001/XMLSchema#string

Charles Marques Lourenco

http://www.w3.org/2001/XMLSchema#string

Chiara Criscuolo

http://www.w3.org/2001/XMLSchema#string

Christine Jägle

http://www.w3.org/2001/XMLSchema#string

Christoph Meisner

http://www.w3.org/2001/XMLSchema#string

Claudia Stendel

http://www.w3.org/2001/XMLSchema#string

Dana M Bis

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration

Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways

Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.

Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients.

Genetic connections between neurological disorders and cholesterol metabolism

ATS statement: guidelines for the six-minute walk test.

Classification of the hereditary ataxias and paraplegias.

A novel cytochrome P450 expressed primarily in brain.

Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening.

Structural and dynamic basis of human cytochrome P450 7B1: a survey of substrate selectivity and major active site access channels.

P304

3112-3127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWX273

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29126212

http://www.w3.org/2001/XMLSchema#string

P932

5841036

http://www.w3.org/2001/XMLSchema#string

Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

about

P2860

P2860

Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932